AE May/June 2021 Vol 30 No 3 - 53

THE #1 MOST
PURCHASED
IN-OFFICE MGD
TREATMENT
DEVICE IN
20191

MGD:

KNOW IT.
CONTROL IT.
Take MGD Management
Into Your Own Hand

The handheld iLUX® MGD Thermal Pulsation System gives you the control to
quickly and effectively treat meibomian gland dysfunction with confidence.
*
*
*
*

Unique light-based heat combined with compression for gland expression
8- to 12-minute personalized, targeted treatments for both eyes
Direct white light visualization for real-time monitoring
More patients treated when combined with support from DEEPTM2 and
SYSTANE® My Eyes patient retention program

Contact iLUX@alcon.com or visit SystaneiLUX.com
for more information.
IMPORTANT PRODUCT INFORMATION FOR iLUX® DEVICE
Indication: The iLUX® Device is indicated for the application of localized heat and pressure therapy in adult patients with chronic
disease of the eyelids, including Meibomian Gland Dysfunction (MGD), also known as evaporative dry eye.
Contraindications: Do NOT use the iLUX® Device in patients with the following conditions: Patients whose pupils have been
pharmaceutically dilated; patients who have undergone ocular surgery within prior 12 months; patients with ocular injury or trauma,
chemical burns, or limbal stem cell deficiency (within prior 3 months); patients with active ocular herpes zoster or simplex of eye or
eyelid or a history of these within prior 3 months; patients with cicatricial lid margin disease; patients with active ocular infection,
active ocular inflammation or history of chronic, recurrent ocular inflammation within prior 3 months; patients with an ocular surface
abnormality that may compromise corneal integrity; patients with lid surface abnormalities that affect lid function in either eye; patients
with aphakia; or patients with permanent makeup or tattoos on their eyelids.
Warnings/Precautions: Federal law restricts this device to sale by or on the order of a licensed healthcare practitioner. The Disposable
may not fit all eyes, such as eyes with small palpebral fornices. Use of the iLUX® device is NOT recommended in patients with the
following conditions: moderate to severe allergic, vernal or giant papillary conjunctivitis; severe eyelid inflammation; systemic disease
conditions that cause dry eye; in patients who are taking medications known to cause dryness; or patients with punctal plugs.
Potential Adverse Reactions: Potential adverse effects may include eyelid/eye pain requiring discontinuation of the treatment
procedure, eyelid irritation or inflammation, temporary reddening of the skin, ocular surface irritation or inflammation (e.g., corneal
abrasion, conjunctive edema or conjunctival injection (hyperemia)), and ocular symptoms (e.g., burning, stinging, tearing, itching,
discharge, redness, foreign body sensation, visual disturbance, sensitivity to light).
Attention: Please refer to the User Manual for a complete list of contraindications, instructions for use, warnings and precautions for
the iLUX® Device.
References:
1. Alcon data on file, 2019.
2. Alcon data on file, 2019.
© 2020 Alcon Inc.

3/20

US-ILU-2000037


http://www.SystaneiLUX.com

AE May/June 2021 Vol 30 No 3

Table of Contents for the Digital Edition of AE May/June 2021 Vol 30 No 3

AE May/June 2021 Vol 30 No 3 - Cover1
AE May/June 2021 Vol 30 No 3 - Cover2
AE May/June 2021 Vol 30 No 3 - 1
AE May/June 2021 Vol 30 No 3 - 2
AE May/June 2021 Vol 30 No 3 - 3
AE May/June 2021 Vol 30 No 3 - 4
AE May/June 2021 Vol 30 No 3 - 5
AE May/June 2021 Vol 30 No 3 - 6
AE May/June 2021 Vol 30 No 3 - 7
AE May/June 2021 Vol 30 No 3 - 8
AE May/June 2021 Vol 30 No 3 - 9
AE May/June 2021 Vol 30 No 3 - 10
AE May/June 2021 Vol 30 No 3 - 11
AE May/June 2021 Vol 30 No 3 - 12
AE May/June 2021 Vol 30 No 3 - 13
AE May/June 2021 Vol 30 No 3 - 14
AE May/June 2021 Vol 30 No 3 - 15
AE May/June 2021 Vol 30 No 3 - 16
AE May/June 2021 Vol 30 No 3 - 17
AE May/June 2021 Vol 30 No 3 - 18
AE May/June 2021 Vol 30 No 3 - 19
AE May/June 2021 Vol 30 No 3 - 20
AE May/June 2021 Vol 30 No 3 - 21
AE May/June 2021 Vol 30 No 3 - 22
AE May/June 2021 Vol 30 No 3 - 23
AE May/June 2021 Vol 30 No 3 - 24
AE May/June 2021 Vol 30 No 3 - 25
AE May/June 2021 Vol 30 No 3 - 26
AE May/June 2021 Vol 30 No 3 - 27
AE May/June 2021 Vol 30 No 3 - 28
AE May/June 2021 Vol 30 No 3 - 29
AE May/June 2021 Vol 30 No 3 - 30
AE May/June 2021 Vol 30 No 3 - 31
AE May/June 2021 Vol 30 No 3 - 32
AE May/June 2021 Vol 30 No 3 - 33
AE May/June 2021 Vol 30 No 3 - 34
AE May/June 2021 Vol 30 No 3 - 35
AE May/June 2021 Vol 30 No 3 - 36
AE May/June 2021 Vol 30 No 3 - 37
AE May/June 2021 Vol 30 No 3 - 38
AE May/June 2021 Vol 30 No 3 - 39
AE May/June 2021 Vol 30 No 3 - 40
AE May/June 2021 Vol 30 No 3 - 41
AE May/June 2021 Vol 30 No 3 - 42
AE May/June 2021 Vol 30 No 3 - 43
AE May/June 2021 Vol 30 No 3 - 44
AE May/June 2021 Vol 30 No 3 - 45
AE May/June 2021 Vol 30 No 3 - 46
AE May/June 2021 Vol 30 No 3 - 47
AE May/June 2021 Vol 30 No 3 - 48
AE May/June 2021 Vol 30 No 3 - 49
AE May/June 2021 Vol 30 No 3 - 50
AE May/June 2021 Vol 30 No 3 - 51
AE May/June 2021 Vol 30 No 3 - 52
AE May/June 2021 Vol 30 No 3 - 53
AE May/June 2021 Vol 30 No 3 - 54
AE May/June 2021 Vol 30 No 3 - 55
AE May/June 2021 Vol 30 No 3 - 56
AE May/June 2021 Vol 30 No 3 - 57
AE May/June 2021 Vol 30 No 3 - 58
AE May/June 2021 Vol 30 No 3 - 59
AE May/June 2021 Vol 30 No 3 - 60
AE May/June 2021 Vol 30 No 3 - Cover3
AE May/June 2021 Vol 30 No 3 - Cover4
https://www.nxtbook.com/ygsreprints/ASOA/ae-may-june-2021-vol-30-no-3
https://www.nxtbook.com/ygsreprints/ASOA/ae-march-april-2021-vol-30-no-2
https://www.nxtbook.com/ygsreprints/ASOA/ae-january-february-2021-vol-30-no-1
https://www.nxtbook.com/ygsreprints/ASOA/ae_nov_dec_20
https://www.nxtbook.com/ygsreprints/ASOA/ae_sept_aug_20
https://www.nxtbook.com/ygsreprints/ASOA/ae_july_aug_20
https://www.nxtbook.com/ygsreprints/ASOA/ae_may_jun_20
https://www.nxtbook.com/ygsreprints/ASOA/ae_mar_apr_20
https://www.nxtbook.com/ygsreprints/ASOA/ae_jan_feb_20
https://www.nxtbook.com/ygsreprints/ASOA/ae_nov_dec19
https://www.nxtbook.com/ygsreprints/ASOA/ae_septoct19
https://www.nxtbook.com/ygsreprints/ASOA/g107843_ae_julyaug19
https://www.nxtbook.com/ygsreprints/ASOA/g105962_ae_mayjun19
https://www.nxtbook.com/ygsreprints/ASOA/g104576_ae_marapr19
https://www.nxtbook.com/ygsreprints/ASOA/g103212_ae_janfeb19
https://www.nxtbook.com/ygsreprints/ASOA/g99529_ae_novdec18
https://www.nxtbook.com/ygsreprints/ASOA/g97160_ae_septoct18
https://www.nxtbook.com/ygsreprints/ASOA/g96528_ae_julyaugust18
https://www.nxtbook.com/ygsreprints/ASOA/g93925_ae_mayjune18
https://www.nxtbook.com/ygsreprints/ASOA/g92298_ae_marapr18
https://www.nxtbook.com/ygsreprints/ASOA/g89361_ae_janfeb18
https://www.nxtbook.com/ygsreprints/ASOA/g86698_ae_novdec17
https://www.nxtbook.com/ygsreprints/ASOA/g81746_ae_septoct17
https://www.nxtbook.com/ygsreprints/ASOA/g80299_ae_julaug17
https://www.nxtbook.com/ygsreprints/ASOA/g77256_ae_mayjun17
https://www.nxtbook.com/ygsreprints/ASOA/g74401_ae_marapr17
https://www.nxtbook.com/ygsreprints/ASOA/g72340_ae_janfeb17
https://www.nxtbook.com/ygsreprints/ASOA/ae_novdec16
https://www.nxtbook.com/ygsreprints/ASOA/ae_septoct16
https://www.nxtbook.com/ygsreprints/ASOA/ae_julaug16
https://www.nxtbook.com/ygsreprints/ASOA/asoa_mayjune2016
https://www.nxtbook.com/ygsreprints/ASOA/asoa_marapr2016
https://www.nxtbook.com/ygsreprints/ASOA/asoa_janfeb16
https://www.nxtbook.com/ygsreprints/ASOA/ae_novdec15
https://www.nxtbook.com/ygsreprints/ASOA/asoa_sepoct15
https://www.nxtbook.com/ygsreprints/APTA/g52750_apta_25ada
https://www.nxtbook.com/ygsreprints/ASOA/asoa_julyaug2015
https://www.nxtbook.com/ygsreprints/ASOA/asoa_mayjune2015
https://www.nxtbook.com/ygsreprints/ASOA/asoa_marapr2015
https://www.nxtbook.com/ygsreprints/ASOA/asoa_janfeb15
https://www.nxtbook.com/ygsreprints/ASOA/asoa_novdec14
https://www.nxtbook.com/ygsreprints/ASOA/asoa_sepoct14_AE
https://www.nxtbook.com/ygsreprints/ASOA/asoa_julaug14
https://www.nxtbook.com/ygsreprints/ASOA/ASOA_MayJunAE
https://www.nxtbook.com/ygsreprints/ASOA/ASOA_MarAprAE
https://www.nxtbook.com/ygsreprints/ASOA/ASOA_JanFebAE
https://www.nxtbook.com/ygsreprints/ASOA/ASOA_no4eZine
https://www.nxtbook.com/ygsreprints/ASOA/asoa_fall_2013
https://www.nxtbook.com/ygsreprints/ASOA/asoa_no3_ezine
https://www.nxtbook.com/ygsreprints/ASOA/asoa/asoa_summer_2013
https://www.nxtbook.com/ygsreprints/ASOA/ehr_cust_survey_Apr2013
https://www.nxtbook.com/ygsreprints/ASOA/asoa_no2_2013_ezine
https://www.nxtbookmedia.com